The antimicrobial peptide LI14 combats multidrug-resistant bacterial infections
A synthetic peptide LI14 demonstrates potent antibacterial activity against drug-resistant bacteria in vitro and in vivo by inducing membrane damage and disrupting membrane potential leading to metabolic perturbation.
Main Authors: | Jingru Shi, Chen Chen, Dejuan Wang, Zhiqiang Wang, Yuan Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-09-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-022-03899-4 |
Similar Items
-
Truncated Pleurocidin Derivative with High Pepsin Hydrolysis Resistance to Combat Multidrug-Resistant Pathogens
by: Dejuan Wang, et al.
Published: (2022-09-01) -
Amphipathic Peptide Antibiotics with Potent Activity against Multidrug-Resistant Pathogens
by: Jingru Shi, et al.
Published: (2021-03-01) -
IR780 Based Sonotherapeutic Nanoparticles to Combat Multidrug-Resistant Bacterial Infections
by: Biying Huang, et al.
Published: (2022-01-01) -
Is antibacterial PNA the answer for combating multidrug resistant bacterial infections?
by: Ghosal, Anubrata
Published: (2017) -
Engineered Cationic Antimicrobial Peptides (eCAPs) to Combat Multidrug-Resistant Bacteria
by: Berthony Deslouches, et al.
Published: (2020-05-01)